Boston Scientific buys Nalu Medical for $533 million

Core Viewpoint - Boston Scientific is acquiring Nalu Medical for approximately $533 million in cash, which will enhance its offerings in the chronic pain management sector [1] Company Summary - The acquisition of Nalu Medical will allow Boston Scientific to expand its product portfolio specifically targeting chronic pain [1] - The cash payment for the acquisition is reported to be around $533 million, indicating a significant investment by Boston Scientific in this area [1] Industry Summary - This acquisition reflects a growing trend in the medical device industry towards addressing chronic pain, which is a major health concern for many patients [1] - By integrating Nalu Medical's technologies, Boston Scientific aims to strengthen its position in the competitive landscape of pain management solutions [1]